Anhui Anke BioTech Group - Asset Resilience Ratio

Latest as of September 2025: 24.77%

Anhui Anke BioTech Group (300009) has an Asset Resilience Ratio of 24.77% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Anhui Anke BioTech Group (300009) total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥1.26 Billion

≈ $184.86 Million USD Cash + Short-term Investments

Total Assets

CN¥5.10 Billion

≈ $746.38 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2024)

This chart shows how Anhui Anke BioTech Group's Asset Resilience Ratio has changed over time. See 300009 book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Anhui Anke BioTech Group's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 300009 company net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.26 Billion	24.77%
Total Liquid Assets	CN¥1.26 Billion	24.77%

Asset Resilience Insights

Good Liquidity Position: Anhui Anke BioTech Group maintains a healthy 24.77% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Anhui Anke BioTech Group Industry Peers by Asset Resilience Ratio

Compare Anhui Anke BioTech Group's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Fortress Biotech Inc NASDAQ:FBIO	Biotechnology	11.59%
Summit Therapeutics PLC NASDAQ:SMMT	Biotechnology	0.00%
Tubize-Fin BR:TUB	Biotechnology	0.05%
Apellis Pharmaceuticals Inc NASDAQ:APLS	Biotechnology	0.58%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
BrightGene Bio Medical Technology C SHG:688166	Biotechnology	1.00%
BioArctic AB (publ) ST:BIOA-B	Biotechnology	72.35%
Chengzhi Shareholding Co Ltd SHE:000990	Biotechnology	6.73%

Annual Asset Resilience Ratio for Anhui Anke BioTech Group (2014–2024)

The table below shows the annual Asset Resilience Ratio data for Anhui Anke BioTech Group.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	22.29%	CN¥1.14 Billion ≈ $167.51 Million	CN¥5.14 Billion ≈ $751.46 Million	-1.86pp
2023-12-31	24.15%	CN¥1.20 Billion ≈ $174.95 Million	CN¥4.95 Billion ≈ $724.45 Million	+4.34pp
2022-12-31	19.81%	CN¥842.91 Million ≈ $123.34 Million	CN¥4.26 Billion ≈ $622.69 Million	-2.14pp
2021-12-31	21.95%	CN¥805.43 Million ≈ $117.86 Million	CN¥3.67 Billion ≈ $536.90 Million	+3.51pp
2020-12-31	18.44%	CN¥646.45 Million ≈ $94.60 Million	CN¥3.50 Billion ≈ $512.87 Million	+12.93pp
2019-12-31	5.51%	CN¥177.85 Million ≈ $26.02 Million	CN¥3.23 Billion ≈ $472.10 Million	+3.34pp
2017-12-31	2.17%	CN¥48.99 Million ≈ $7.17 Million	CN¥2.25 Billion ≈ $329.85 Million	-0.98pp
2016-12-31	3.15%	CN¥62.00 Million ≈ $9.07 Million	CN¥1.97 Billion ≈ $287.58 Million	-3.63pp
2015-12-31	6.79%	CN¥95.10 Million ≈ $13.92 Million	CN¥1.40 Billion ≈ $205.05 Million	+6.35pp
2014-12-31	0.44%	CN¥4.00 Million ≈ $585.33K	CN¥915.58 Million ≈ $133.98 Million	--

pp = percentage points

About Anhui Anke BioTech Group

SHE:300009 China Biotechnology

Market Cap

$2.16 Billion

CN¥14.77 Billion CNY

Market Cap Rank

#5973 Global

#1280 in China

Share Price

CN¥8.84

Change (1 day)

-1.23%

52-Week Range

CN¥8.24 - CN¥12.30

All Time High

CN¥127.71